Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.
Novosanis research grant
Novosanis is offering a research grant in collaboration with EACR to stimulate innovative research in cancer biomarker detection using urine as a sample type. Urine can be collected in an easy, quick and non-invasive way, and has shown potential to change the way cancer is detected and monitored...
Novosanis is excited to present a booth at ISLB, an international conference focusing on liquid biopsy. The congress takes place virtually on 22 October. Our team is excited to share the potential of urine as a liquid biopsy, especially in the field of oncology, during a presentation at the...